Osimertinib-associated ashy dermatosis–like hyperpigmentation

Osimertinib-associated ashy dermatosis–like hyperpigmentation

Bibliographic Details
Main Authors:	Pattamon Lertpichitkul, MD, Jade Wititsuwannakul, MD, Pravit Asawanonda, MD, DSc, Pawinee Rerknimitr, MD, MSc
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Series:	JAAD Case Reports
Subjects:	ashy epidermal growth factor receptor inhibitor hyperpigmentation osimertinib rash
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512619307052

Similar Items

Rare ashy dermatosis‐like hyperpigmentation associated with osimertinib
by: Kazuhito Funai
Published: (2022-05-01)

Osimertinib-associated erythema dyschromicum perstans–like eruption: A case series
by: Christina S. Oh, BA, et al.
Published: (2023-05-01)

Ashy dermatosis: A comprehensive review
by: Bibush Amatya
Published: (2017-04-01)

Lichen planus pigmetosus-like ashy dermatosis
by: Francesco Tripodi Cutrì, et al.
Published: (2011-12-01)

Ashy dermatosis in a child
by: D. V. Proshutinskaya, et al.
Published: (2019-05-01)

Two Cases of Unilateral Ashy Dermatosis
by: Hisayoshi Imanishi, et al.
Published: (2011-01-01)

Dermoscopic diagnosis of ashy dermatosis: A retrospective study
by: Ömer Faruk Elmas, et al.
Published: (2019-01-01)

Ashy dermatosis with involvement of mucous membranes
by: Margarida Rato, et al.
Published: (2017-01-01)

Erythema Dyschromicum Perstans: Identical to Ashy Dermatosis or Not
by: Takafumi Numata, et al.
Published: (2015-07-01)

Erythema dyschromicum perstans (ashy dermatosis) – opis przypadków
by: Jadwiga Roszkiewicz, et al.
Published: (2011-08-01)

Ashy dermatosis with a Wagyu beef‐like dermoscopic appearance: Report of two cases
by: Yuki Munekata, et al.
Published: (2023-03-01)

Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease
by: Michał Sobjanek, et al.
Published: (2014-03-01)

Histological evaluation of acquired dermal macular hyperpigmentation
by: Sarita Sasidharanpillai, et al.
Published: (2019-01-01)

Ashis Nandy e as vicissitudes do self: crítica, subjetividade e civilização indiana
by: José Maurício Domingues
Published: (2010-04-01)

Erythema dyschromicum perstans in pregnancy
by: Shagufta Rather, et al.
Published: (2018-01-01)

Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
by: Andrew J. Piper-Vallillo, MD, et al.
Published: (2020-03-01)

Pengembangan Al-Ghazali’s Sufism Happiness Inventory (ASHI):Sebuah Pengukuran Kebahagiaan Sufi
by: Arman Marwing
Published: (2018-11-01)

Postinflammatory hyperpigmentation?
by: Anca Chiriac
Published: (2013-06-01)

Postinflammatory hyperpigmentation ?
by: Anca Chiriac
Published: (2013-06-01)

Facial hyperpigmentation and crusted papules on the hands
by: Audrey C. Leasure, BS, et al.
Published: (2022-02-01)

Oral mucosal hyperpigmentation
by: Karen Lee, BS, et al.
Published: (2020-10-01)

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease
by: Molly S.C. Li, M.B.B.S., et al.
Published: (2024-04-01)

Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature
by: Christopher Iriarte, MD, et al.
Published: (2022-11-01)

Ashi Scalp Acupuncture in the Treatment of Secondary Trigeminal Neuralgia Induced by Multiple Sclerosis: A Case Report
by: Qiong Schürer, et al.
Published: (2022-08-01)

Osimertinib Re-challenge for EGFR-mutant NSCLC after  Osimertinib-induced Interstitial Lung Disease: A Case Report
by: Junjie GU, et al.
Published: (2021-11-01)

The genome sequence of the Ashy Button, Acleris sparsana (Denis & Schiffermüller, 1775) [version 1; peer review: 2 approved]
by: Douglas Boyes, et al.
Published: (2023-06-01)

Terra Firma-Forme Dermatosis
by: Adelina Costin, et al.
Published: (2020-05-01)

Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib∗
by: Andrew J. Piper-Vallillo, MD, et al.
Published: (2019-12-01)

Similarities between Ashi acupoints and myofascial trigger points: Exploring the relationship between body surface treatment points
by: Seoyoung Lee, et al.
Published: (2022-11-01)

Cutaneous Hyperpigmentation in General Practice
by: Kumpol Aiempanakit
Published: (2015-06-01)

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib
by: Sun Min Lim, MD, PhD, et al.
Published: (2021-06-01)

Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy
by: Kanika Sahni, et al.
Published: (2014-01-01)

Kratom as a novel cause of photodistributed hyperpigmentation
by: Landon R. Powell, BS, et al.
Published: (2022-10-01)

Polymyxin B-induced skin and nail hyperpigmentation in an adult
by: Mahendra M Kura, et al.
Published: (2023-01-01)

Dermatology: how to manage facial hyperpigmentation in skin of colour
by: Siddiq Moolla, et al.
Published: (2022-05-01)

Treatment of imipramine-induced hyperpigmentation with quality-switched ruby and picosecond lasers
by: Ramiz Nayyer Hamid, MD, MPH, et al.
Published: (2021-11-01)

Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations
by: Yuki Takeyasu, MD, et al.
Published: (2024-02-01)

Erythema dyschromicum perstans: Response to topical tacrolimus
by: Vikram K Mahajan, et al.
Published: (2015-01-01)

Osimertinib-Induced Cardiomyopathy
by: Shruti R. Patel, MD, et al.
Published: (2020-04-01)

Aetiological Factors of Periorbital Hyperpigmentation in Patients Presenting to the Hospital
by: Amna Nasar, et al.
Published: (2023-06-01)